Quick Answer
Moleculin Biotech, Inc. reported Total Assets of $22.13 million for fiscal year 2025.
Moleculin Biotech, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $22.13M | +30.7% |
| 2024 | $16.93M | -55.7% |
| 2023 | $38.22M | -33.4% |
| 2022 | $57.42M | -31.7% |
| 2021 | $84.09M | +189.7% |
| 2020 | $29.03M | +15.0% |
| 2019 | $25.23M | +28.8% |
| 2018 | $19.59M | +0.5% |
| 2017 | $19.48M | +18.8% |
| 2016 | $16.39M | +58256.8% |
| 2015 | $28.1K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $20.35M | -13.0% | -5.7% |
| June 30, 2025 | $21.59M | -15.6% | +2.8% |
| March 31, 2025 | $21.01M | -31.9% | +24.2% |
| December 31, 2024 | $16.93M | -55.7% | -27.7% |
| September 30, 2024 | $23.39M | -40.8% | -8.5% |
| June 30, 2024 | $25.57M | -45.7% | -17.1% |
| March 31, 2024 | $30.84M | -39.6% | -19.3% |
| December 31, 2023 | $38.22M | -33.4% | -3.3% |
- Moleculin Biotech, Inc. showed an increase of +30.7% in Total Assets compared to the prior fiscal year.
- Over the 2015–2025 period, Moleculin Biotech, Inc.’s total assets has grown by 78665.4% (from $28.1 thousand to $22.13 million).
- The most recent figure is from Moleculin Biotech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: